AAAAAA

   
Results: 1-16 |
Results: 16
EXPOSURE TO EXTRACELLULAR IONIZED CALCIUM IN HEMODIALYSIS-PATIENTS WITH ADYNAMIC BONE-DISEASE AND HYPERPARATHYROID BONE-DISEASE
Authors: COUTTENYE MM DHAESE PC JURGENS A PIESSENS A LAMBRECHTS M VERPOOTEN GA DEBROE ME
Citation: Mm. Couttenye et al., EXPOSURE TO EXTRACELLULAR IONIZED CALCIUM IN HEMODIALYSIS-PATIENTS WITH ADYNAMIC BONE-DISEASE AND HYPERPARATHYROID BONE-DISEASE, Journal of the American Society of Nephrology, 8, 1997, pp. 2560-2560
HIGH PREVALENCE OF ADYNAMIC BONE-DISEASE DIAGNOSED BY BIOCHEMICAL MARKERS IN A WIDE SAMPLE OF THE EUROPEAN CAPD POPULATION
Authors: COUTTENYE MM DHAESE PC DENG JT VANHOOF VO VERPOOTEN GA DEBROE ME
Citation: Mm. Couttenye et al., HIGH PREVALENCE OF ADYNAMIC BONE-DISEASE DIAGNOSED BY BIOCHEMICAL MARKERS IN A WIDE SAMPLE OF THE EUROPEAN CAPD POPULATION, Nephrology, dialysis, transplantation, 12(10), 1997, pp. 2144-2150
IS THERE A LINK BETWEEN ERYTHROPOIETIN THERAPY AND ADYNAMIC BONE-DISEASE
Authors: SMANS KA VANLANDEGHEM GF DHAESE PC COUTTENYE MM DEBROE ME
Citation: Ka. Smans et al., IS THERE A LINK BETWEEN ERYTHROPOIETIN THERAPY AND ADYNAMIC BONE-DISEASE, Nephrology, dialysis, transplantation, 11(7), 1996, pp. 1248-1249
LOW SERUM LEVELS OF ALKALINE-PHOSPHATASE OF BONE ORIGIN - A GOOD MARKER OF ADYNAMIC BONE-DISEASE IN HEMODIALYSIS-PATIENTS
Authors: COUTTENYE MM DHAESE PC VANHOOF VO LEMONIATOU E GOODMAN W VERPOOTEN GA DEBROE ME
Citation: Mm. Couttenye et al., LOW SERUM LEVELS OF ALKALINE-PHOSPHATASE OF BONE ORIGIN - A GOOD MARKER OF ADYNAMIC BONE-DISEASE IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 11(6), 1996, pp. 1065-1072
DIAGNOSIS AND TREATMENT OF ALUMINUM BONE-DISEASE
Authors: DHAESE PC COUTTENYE MM DEBROE ME
Citation: Pc. Dhaese et al., DIAGNOSIS AND TREATMENT OF ALUMINUM BONE-DISEASE, Nephrology, dialysis, transplantation, 11, 1996, pp. 74-79
HERPES-ZOSTER MYELITIS OCCURRING DURING TREATMENT FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: EBO DG DECLERCK LS STEVENS WJ IEVEN M URSI D VANGOETHEM JW COUTTENYE MM
Citation: Dg. Ebo et al., HERPES-ZOSTER MYELITIS OCCURRING DURING TREATMENT FOR SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of rheumatology, 23(3), 1996, pp. 548-550
DETERMINATION OF IONIZED CALCIUM - EVALUATION OF SAMPLING AND STORAGEPROCEDURES
Authors: COUTTENYE MM JURGENS A LAMBERTS LV VERPOOTEN GA DHAESE PC DEBROE ME
Citation: Mm. Couttenye et al., DETERMINATION OF IONIZED CALCIUM - EVALUATION OF SAMPLING AND STORAGEPROCEDURES, Clinical chemistry, 42(3), 1996, pp. 468-469
BONE TRACE-METAL ALTERATIONS IN RENAL OSTEODYSTROPHY
Authors: DHAESE PC LAMBERTS LV COUTTENYE MM GOODMAN WG DEBROE ME
Citation: Pc. Dhaese et al., BONE TRACE-METAL ALTERATIONS IN RENAL OSTEODYSTROPHY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 934-934
INCREASED STRONTIUM LEVELS IN BONE OF DIALYSIS PATIENTS WITH OSTEOMALACIA
Authors: DHAESE PC COUTTENYE MM LAMBERTS LV GOODMAN WG DEBROE ME
Citation: Pc. Dhaese et al., INCREASED STRONTIUM LEVELS IN BONE OF DIALYSIS PATIENTS WITH OSTEOMALACIA, Journal of the American Society of Nephrology, 6(3), 1995, pp. 935-935
USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD
Authors: DHAESE PC COUTTENYE MM GOODMAN WG LEMONIATOU E DIGENIS P SOTORNIK I FAGALDE A BARSOUM RS LAMBERTS LV DEBROE ME
Citation: Pc. Dhaese et al., USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD, Nephrology, dialysis, transplantation, 10(10), 1995, pp. 1874-1884
LOW BONE ALKALINE-PHOSPHATASE - A SENSITI VE, SPECIFIC MARKER FOR ADYNAMIC BONE-DISEASE IN DIALYSIS PATIENTS
Authors: COUTTENYE MM DEBROE ME
Citation: Mm. Couttenye et Me. Debroe, LOW BONE ALKALINE-PHOSPHATASE - A SENSITI VE, SPECIFIC MARKER FOR ADYNAMIC BONE-DISEASE IN DIALYSIS PATIENTS, Nieren- und Hochdruckkrankheiten, 24(8), 1995, pp. 380-383
IMMUNORADIOMETRIC METHOD AND ELECTROPHORETIC SYSTEM COMPARED FOR QUANTIFYING BONE ALKALINE-PHOSPHATASE IN SERUM
Authors: VANHOOF VO MARTIN M BLOCKX P PROVE A VANOOSTEROM A COUTTENYE MM DEBROE ME LEPOUTRE LG
Citation: Vo. Vanhoof et al., IMMUNORADIOMETRIC METHOD AND ELECTROPHORETIC SYSTEM COMPARED FOR QUANTIFYING BONE ALKALINE-PHOSPHATASE IN SERUM, Clinical chemistry, 41(6), 1995, pp. 853-857
UPTAKE OF ALUMINUM (AL) BY THE PARATHYROID CELLS (PTC) VIA TRANSFERRIN RECEPTOR (TFR)-MEDIATED ENDOCYTOSIS MAY CONTRIBUTE TO THE DEVELOPMENT OF HYPOPARATHYROIDISM IN ADYNAMIC BONE-DISEASE (ABD)
Authors: SMANS KA DHAESE PC LAMBERTS LV VANLANDEGHEM GF COUTTENYE MM DEBROE ME
Citation: Ka. Smans et al., UPTAKE OF ALUMINUM (AL) BY THE PARATHYROID CELLS (PTC) VIA TRANSFERRIN RECEPTOR (TFR)-MEDIATED ENDOCYTOSIS MAY CONTRIBUTE TO THE DEVELOPMENT OF HYPOPARATHYROIDISM IN ADYNAMIC BONE-DISEASE (ABD), Journal of the American Society of Nephrology, 5(3), 1994, pp. 889-889
VALUE OF THE LOW-DOSE DESFERRIOXAMINE (DFO) TEST IN THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE (ARBD) IN DIALYSIS (D) PATIENTS
Authors: DHAESE PC COUTTENYE MM LAMBERTS LV GOODMAN WG NUYTS GD LEMONIATOU E DIGENIS P SOTORNIK I FAGALDE A DEBROE ME
Citation: Pc. Dhaese et al., VALUE OF THE LOW-DOSE DESFERRIOXAMINE (DFO) TEST IN THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE (ARBD) IN DIALYSIS (D) PATIENTS, Kidney international, 46(5), 1994, pp. 1461-1461
NEW INSIGHTS AND STRATEGIES IN THE DIAGNOSIS AND TREATMENT OF ALUMINUM OVERLOAD IN DIALYSIS PATIENTS
Authors: DEBROE ME DHAESE PC COUTTENYE MM VANLANDEGHEM GF LAMBERTS LV
Citation: Me. Debroe et al., NEW INSIGHTS AND STRATEGIES IN THE DIAGNOSIS AND TREATMENT OF ALUMINUM OVERLOAD IN DIALYSIS PATIENTS, Nephrology, dialysis, transplantation, 8, 1993, pp. 47-50
HIGHER SERUM ALUMINUM CONCENTRATIONS IN IRON-DEPLETED DIALYSIS PATIENTS
Authors: VANUYTSEL JL DHAESE PC COUTTENYE MM DEBROE ME
Citation: Jl. Vanuytsel et al., HIGHER SERUM ALUMINUM CONCENTRATIONS IN IRON-DEPLETED DIALYSIS PATIENTS, Nephrology, dialysis, transplantation, 7(2), 1992, pp. 177-177
Risultati: 1-16 |